SURVYR

Biotech ETFs

Drug developers, genomics and medical research companies.All themesCompare funds

5 biotech ETFs; 5 have holdings filed with the SEC. Most alike: BBH and IBB (59% overlap). Least alike: BBH and SBIO (0%).

Funds with holdings
5 of 5
filed with the SEC
Most overlap
59%
BBH and IBB
Least overlap
0%
BBH and SBIO
Expense ratios
0.35–0.75%
5 funds with data

How much they overlap

How much of each pair is the same stocks at the same weights (100% = identical). Tap a square to compare that pair.

XBIIBBARKGBBHSBIO
XBI—42%10%15%29%
IBB42%—10%59%10%
ARKG10%10%—8%0%
BBH15%59%8%—0%
SBIO29%10%0%0%—
Pick two to compare:

The funds

Expense ratio = the yearly fee, as a share of your money in the fund. The lowest is marked. Top 10 = share of the fund in its 10 largest holdings.

FundIssuerExpense ratioHoldingsTop 10As of
State Street SPDR S&P Biotech ETFXBI State Street 0.35%Lowest 15213%Jun 30, 2026
iShares Biotechnology ETFIBB iShares 0.44% 24845%Jun 30, 2026
ARK Genomic Revolution ETFARKG ARK 0.75% 3259%Jul 31, 2026
VanEck Biotech ETFBBH VanEck 0.35%Lowest 2470%Jun 30, 2026
ALPS Medical Breakthroughs ETFSBIO ALPS 0.50% 8235%May 31, 2026
How this works & disclosures

The fund list is picked by SURVYR. from US-listed ETFs registered with the SEC; leveraged and inverse funds are left out, and being on the list isn’t a view on the fund. Holdings are from each fund’s latest public Form N-PORT on SEC EDGAR (as-of dates in the table) and change over time; funds launched in the last few months may not have filed one yet.

Overlap by weight adds up, for every holding both funds own, the smaller of its two weights. Sub-themes are assigned by SURVYR. from each company’s main line of business; anything not assigned is in Other, and bars leave out cash. Expense ratios come from each fund’s prospectus (Form 485BPOS) fee table on SEC EDGAR; a dash means it wasn’t machine-readable there.

Data from SEC Form N-PORT, the holdings report funds file with the SEC each quarter; the SEC makes it public about 60 days after the quarter ends. Holdings change; this may be out of date. SURVYR. describes what funds hold and how they have done; it does not manage money or give advice. Not investment advice. Full disclosures

Data from SEC filings. Holdings change; this may be out of date. Not investment advice. Disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026